Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction

American Journal of the Medical Sciences

Volumn 352, Issue 3, 2016, Pages 261-266

  Ren, Faxin ^a   Mu, Nan ^a   Zhang, Xia ^a   Tan, Jinxi ^a   Li, Liudong ^a   Zhang, Chuanhuan ^a   Dong, Mei ^a  

^a YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Inflammation reaction; No reflow; Platelet leukocyte aggregates; Thrombosis

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; DIABETES MELLITUS; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PLATELET LEUKOCYTE AGGERGATE; PLATELET LYMPHOCYTE AGGREGATE; PLATELET MONOCYTE AGGREGATE; PLATELET NEUTROPHIL AGGREGATE; PREDICTIVE VALUE; PREDICTOR VARIABLE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; THROMBUS; ANALOGS AND DERIVATIVES; BLOOD; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY THROMBOSIS; ELECTROCARDIOGRAPHY; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PATHOLOGY; RETROSPECTIVE STUDY; THROMBOCYTE;

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; TICLOPIDINE;

ASPIRIN; BLOOD PLATELETS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY THROMBOSIS; ELECTROCARDIOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TICLOPIDINE;

EID: 85020374840     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1016/j.amjms.2016.05.034     Document Type: Article

References (34)

1. Kloner, R.A., Ganote, C.E., Jennings, R.B., The ‘no-reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974), 1496–1508.
2. Ito, H., Etiology and clinical implications of microvascular dysfunction in patients with acute myocardial infarction. Int Heart J 55 (2014), 185–189.
3. Stone, G.W., Peterson, M.A., Lansky, A.J., et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 39 (2002), 591–597.
4. Morishima, I., Sone, T., Okumura, K., et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000), 1202–1209.
5. Lee, C.H., Tse, H.F., Microvascular obstruction after percutaneous coronary intervention. Catheter Cardiovasc Interv 75 (2010), 369–377.
6. Danenberg, H.D., Kantak, N., Grad, E., et al. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol 78 (2007), 246–252.
7. Furman, M.I., Barnard, M.R., Krueger, L.A., et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38 (2001), 1002–1006.
8. Faraday, N., Braunstein, J.B., Heldman, A.W., et al. Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. Platelets 15 (2004), 9–14.
9. Cerletti, C., de Gaetano, G., Lorenzet, R., Platelet-leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. Mediterr J Hematol Infect Dis, 2, 2010, e2010023.
10. Funayama, H., Ishikawa, S.E., Kubo, N., et al. Close association of regional interleukin-6 levels in the infarct-related culprit coronary artery with restenosis in acute myocardial infarction. Circ J 70 (2006), 426–429.
11. de Boer MJ, Reiber JH, Suryapranata H, et al. Angiographic findings and catheterisation laboratory events in patients with primary coronary angioplasty or strep-tokinase therapy for acute myocardial infarction. Eur Heart J 16:1347-55.
12. Gibson, C.M., Cannon, C.P., Murphy, S.A., et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation 99 (1999), 1945–1950.
13. van׳t Hof, A.W., Liem, A., Suryapranata, H., et al. Angiographic assessment of my ocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 97 (1998), 2302–2306.
14. Pasterkamp, G., Schoneveld, A.H., Hijnen, D.J., et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150 (2000), 245–253.
15. Rezkalla, S.H., Kloner, R.A., No-reflow phenomenon. Circulation 105 (2002), 656–662.
16. Gur, M., Turkoqlu, C., Taskın, A., et al. Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow. Atherosclerosis 234 (2014), 415–420.
17. Galasso, G., Schiekofer, S., D'Anna, C., et al. No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives. Angiology 65 (2014), 180–189.
18. Michaels, A.D., Gibson, C.M., Barron, H.V., Microvascular dysfunction in acute myocardial infarction: focus on the role of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol 85 (2000), 50B–60B.
19. Botto, N., Sbrana, S., Trianni, G., et al. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for ‘‘no-reflow’’ phenomenon?. Int J Cardiol 117 (2007), 123–130.
20. Maalej, N., Albrecht, R., Loscalzo, J., et al. The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces. J Am Coll Cardiol 33 (1999), 1408–1414.
21. Mikhailidis, D.P., Ganotakis, E.S., Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets 7 (1996), 125–137.
22. Kurtul, A., Ocek, A.H., Murat, S.N., et al. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Angiology 66 (2015), 278–285.
23. Rinder, H.M., Bonan, J.L., Rinder, C.S., et al. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 78 (1991), 1730–1737.
24. Henn, V., Slupsky, J.R., Grafe, M., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998), 591–594.
25. Hansson, G.K., Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005), 1685–1695.
26. Fuentes, Q.E., Fuentes, Q.F., Andres, V., et al. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 24 (2013), 255–262.
27. Gurbel, P.A., Bliden, K.P., Kreutz, R.P., et al. The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting. Platelets 20 (2009), 97–104.
28. Choi, S.W., Choi, D.H., Kim, H.W., et al. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: implications of more simple and useful test than platelet function testing. Platelets 25 (2014), 322–327.
29. Tantry, U.S., Bliden, K.P., Suarez, T.A., et al. Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: Results of the Thrombotic Risk Progression (TRIP) Study. Platelets 21 (2010), 360–367.
30. Verdoia, M., Secco, G.G., Barbieri, L., et al. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. Platelets 25 (2014), 367–372.
31. Kurtul, A., Murat, S.N., Yarlioglues, M., et al. Mild to moderate renal impairment is associated with no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. Angiology 66 (2015), 644–651.
32. Filiopoulos, V., Vlassopoulos, D., Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets 8 (2009), 369–382.
33. Soylu, K., Yuksel, S., Gulel, O., et al. The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention. J Thorac Dis 5 (2013), 258–264.
34. Landray, M.J., Wheeler, D.C., Lip, G.Y., Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 43 (2004), 244–253.